Login to Your Account



Other News To Note


Tuesday, October 8, 2013
• Debiopharm Group, of Lausanne, Switzerland, signed an exclusive research collaboration with the Experimental Therapeutics Centre at Singapore’s Agency for Science, Technology and Research to develop oral small molecules targeting tumors with genetic lesions.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription